Eliano P Navarese Selected Research

Everolimus

11/2013

Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eliano P Navarese Research Topics

Disease

17	Acute Coronary Syndrome 01/2024 - 04/2012
17	Hemorrhage 12/2023 - 02/2016
14	Myocardial Infarction 12/2023 - 11/2013
7	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 04/2013
6	ST Elevation Myocardial Infarction 01/2024 - 02/2010
6	Thrombosis (Thrombus) 04/2021 - 11/2013
5	Cardiovascular Diseases (Cardiovascular Disease) 06/2024 - 04/2016
4	COVID-19 01/2023 - 01/2020
3	Stroke (Strokes) 12/2023 - 04/2015
2	Atherosclerosis 06/2024 - 01/2020
2	Ischemia 01/2023 - 01/2018
2	Inflammation (Inflammations) 01/2023 - 06/2018
2	Peripheral Arterial Disease 03/2022 - 10/2018
2	Unstable Angina 01/2022 - 01/2017
2	Heart Arrest (Cardiac Arrest) 01/2020 - 07/2017
2	Dyslipidemias (Dyslipidemia) 05/2016 - 04/2016
1	Cardiogenic Shock 01/2024
1	Coronary Thrombosis 12/2023
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2023
1	MINOCA 03/2023
1	Pneumonia (Pneumonitis) 01/2023
1	Atrial Fibrillation 12/2021
1	Intracranial Embolism 12/2021
1	Death (Near-Death Experience) 12/2021
1	Heart Failure 01/2021
1	Aortic Valve Stenosis (Aortic Stenosis) 08/2019
1	Aortic Valve Insufficiency (Aortic Regurgitation) 08/2019
1	Diabetes Mellitus 01/2018
1	Pathologic Constriction (Stenosis) 01/2018
1	Cardiomyopathies (Cardiomyopathy) 07/2017
1	Sudden Death 07/2017
1	Ischemic Stroke 01/2017
1	Non-ST Elevated Myocardial Infarction 01/2017
1	Out-of-Hospital Cardiac Arrest 03/2016
1	Anemia 02/2016
1	Myocardial Ischemia (Ischemic Heart Diseases) 04/2015

Drug/Important Bio-Agent (IBA)

12	TicagrelorIBA 12/2023 - 01/2017
8	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2023 - 01/2018
6	Clopidogrel (Plavix)FDA Link 12/2023 - 04/2013
6	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 12/2023 - 02/2016
5	omega-Chloroacetophenone (Mace)IBA 12/2023 - 01/2018
4	LipidsIBA 06/2024 - 04/2016
4	Prasugrel Hydrochloride FDA Link 12/2023 - 01/2017
4	sirioIBA 01/2023 - 01/2022
4	Proprotein Convertase 9IBA 01/2023 - 04/2016
2	Ion Channels (Ion Channel)IBA 01/2022 - 01/2020
2	AR C124910XXIBA 01/2022 - 01/2017
2	Phenobarbital (Luminal)FDA Link 04/2021 - 01/2018
2	Adenosine Diphosphate (ADP)IBA 10/2020 - 01/2018
2	Thrombin FDA Link 01/2018 - 08/2017
2	FibrinIBA 01/2018 - 08/2017
2	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2018 - 08/2017
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2018 - 04/2013
2	Monoclonal AntibodiesIBA 05/2016 - 04/2016
2	AntibodiesIBA 05/2016 - 04/2016
1	CholesterolIBA 06/2024
1	cangrelorIBA 01/2024
1	Purinergic P2Y Receptor AntagonistsIBA 01/2024
1	Opioid Analgesics (Opioids)IBA 01/2024
1	Purinergic P2Y ReceptorsIBA 12/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2023
1	Oxygen (Dioxygen)IBA 01/2023
1	LDL Receptors (LDL Receptor)IBA 01/2023
1	evolocumabIBA 01/2023
1	Naloxone (Narcan)FDA LinkGeneric 01/2022
1	Amiodarone (Amiodarona)FDA LinkGeneric 01/2022
1	Morphine (MS Contin)FDA LinkGeneric 01/2022
1	Verapamil (Calan)FDA LinkGeneric 01/2022
1	Narcotics (Narcotic Analgesics)IBA 01/2022
1	Vitamin K FDA Link 12/2021
1	ORALIT (ORS)IBA 12/2021
1	N(4)-oleylcytosine arabinosideIBA 12/2021
1	AnticoagulantsIBA 12/2021
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2021
1	LDL CholesterolIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 10/2020
1	CollagenIBA 10/2020
1	RivaroxabanIBA 01/2020
1	EnzymesIBA 06/2018
1	PCSK9 InhibitorsIBA 06/2018
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2018
1	oxidized low density lipoproteinIBA 01/2018
1	CreatinineIBA 02/2016
1	Sirolimus (Rapamycin)FDA Link 11/2013

Therapy/Procedure

21	Therapeutics 12/2023 - 04/2012
8	Percutaneous Coronary Intervention 12/2023 - 02/2016
4	Stents 01/2020 - 11/2013
3	Transcatheter Aortic Valve Replacement 01/2021 - 08/2019
2	Secondary Prevention 03/2023 - 03/2022
2	Cardiopulmonary Resuscitation (CPR) 01/2020 - 03/2016
2	Cell- and Tissue-Based Therapy (Cell Therapy) 04/2016 - 04/2015
1	Induced Hypothermia 01/2024
1	Subcutaneous Injections 01/2023
1	Catheter Ablation 12/2021
1	Drug Tapering 01/2021
1	Resuscitation 01/2020
1	Contraindications 08/2019
1	Precision Medicine 10/2017
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 07/2017
1	Drug-Eluting Stents 03/2016